Endothelial dysfunction and vascular inflammation may be associated with variant angina (VA). The aim of the present study was to investigate whether the level of von Willebrand factor (VWF) and flow-mediated dilation (FMD) are related to VA. This study included 74 patients (VA group: 52.1±11.9 years, 40 males) with normal coronary angiogram (CAG) and positive ergonovine provocation test (ERT), and 33 patients (control group:49.7±10.8 years, 23 males) and normal CAG with negative ERT. The level of VWF was significantly higher in VA than in control group (163.0±43.4% vs. 127.2±59.6%, p=0.008). FMD was significantly decreased in VA group compared with control group (9.0±4.0% vs. 11.2±3.1%, p=0.008). The levels of white blood cell counts was higher in VA than in control group (7509.4±2411.1/mm 3 vs.
Introduction
The prevalence of variant angina (VA) is apparently higher in Korean and Japanesepat-ients than in Caucasian counterparts. 1 4 Endothelial dysfunction is in-volved in every stage of the progression of atherosclerosis 5, 6 and is non-invasively measured by flowmediated dilation (FMD) of the brachial artery. 7 Besides these traditional risk factors, several other risk factors and surrogate markers for the early detection of atherosclerosis including the measurement of endothelial dysfunction, and serologic markers of vascular inflammation have recently been proposed and widely studied. 8 Several studies have suggested that a variety of factors may contribute to endothelial dysfunc-tion in patients with VA. 9 11 These include impaired flow-dependent coronary dilation due to decreased activity of the vasodilator nitric oxide, 12, 13 which in some patients may be the result of mutation in the endothelial nitric oxide synthase gene. Also, inflammation may play a role since patients with VA have elevated serum C-reactive protein concentrations, as reported in one series, were found to be elevated lying between controls and patients with acute coronary syndrome. 14 In addition, there are structural endothelial abnormalities in the arteries that manifest spasm. Intravascular ultrasound examination has shown that, patients with vasospasm have diffuse intimal thickening in the coronary arteries that develop spasm, which is independent of other traditional risk factors for coronary artery disease. 15 These changes may be due in part to local vascular injury induced by vasospasm itself. 16 There are few reports about VA risks. 
Methods

1) Measurement of endothelial function
FMD of brachial artery as the non-invasive parameter of endothelial function was measured according to the guideline described previously. 7 Vasoactive therapies were not prescribed for at least 24 hours before the study until the measurement was completed except for only short-acting sublingual nitroglycerin (NTG), which was withheld 1 hour before the study.
All studies were performed early in the morning condition, 0.6 mg of NTG was administered sublingually.
The brachial artery was continuously imaged for 5 minutes to measure peak diameter. The dilatory response to NTG was used as a measure of endotheliumindependent dilation. Patients with menstruation cycle were excluded from the study, because the varying levels of estrogen may affect endothelial function. In our studies, the intra-and inter-observer variability for the repeated measurements of resting arterial diameter was very satisfactoy (r=0.997, p＜0.001, r=0.997, p＜ 0.001). 
2) Transthoracic echocardiography
4) Laboratory measurements
We measured the blood levels of VWF for examining endothelial function, white blood cell (WBC) counts, high-sensitively C-reactive protein (hs-CPR), homocystein for examining the inflammatory activity, and fibrinogen for the coagulation system. Blood samples Values are presented as numbers (%) or mean±standard deviation. Fig. 1 . The flow-mediated dilation (FMD) was significantly decreased in patients with variant angina (Group I) than in control patients (Group II). However, the nitroglycerin-mediated dilation (NMD) was not different between both groups.
were taken by venipuncture in the morning after fasting for over 12 hours before angiography. VWF was measured by the enzyme-linked immunosorbent assay (ELISA) technique using commercial reagents (R& D systems, USA) and hs-CRP was measured by immunoturbidimetric CRP-Latex (II) assay using Olympus AU 5400. Measurements of fibrinogen was performed by chromogenic assay (Sysmex, CA1500, USA).
5) Statistical analysis
All statistical calculations were performed using SPSS Receiver-operating characteristics (ROC) analysis was used for determining optimal cutoff value defined as the point with the highest sum of sensitivity and specificity.
The area under the ROC curve was used to quantify the ability to predict VA.
Results
Patient characteristics
The clinical characteristics including the risk factors of the study population are summarized in Table 1 .
There was a male predominance in Group I and II.
However, there was no significant difference.
Biochemical markers
Comparison of the biochemical markers is summarized in Table 2 . The levels of hs-CRP, fibrinogen, homocysteine were not different between the two groups.
However, the levels of WBC counts and of total cholesterol were significantly elevated in Group I than in Group II. To be of note, however, was the level of VWF significantly elevated in Group I compared with Group II.
FMD, NTG-mediated dilation, and brachial blood flow
The data on FMD, NTG-mediated dilation, and brachial blood flow are shown in Table 3 . FMD was significantly decreased in Group I compared with Group II. No significant differences were found in NTGmediated dilation, and basal flow and hyperdynamic flow (Fig. 1 ).
Independent predictors of VA
Multiple logistic regression analysis was performed to determine independent predictors of VA. All variables with p＜0.05 in univariate analysis were tested. The independent predictive factors of VA are shown in and FMD ＜10% provided the best separation of patients with and without VA (sensitivity 0.66, specificity 0.69, respectively) ( Fig. 2) .
Discussion
In the present study, significantly impaired brachial artery FMD and significantly increased level of VWF were observed in VA patients compared with age- The vascular endothelium has been reported to be a multifunctional organ whose integrity is essential for normal vascular physiology. 17, 18 Decreased flow-mediated dilation in patients with VA has recently been reported, 11, 19 and there is growing evidence that endothelial function abnormalities are present before the development of angiographically evident coronary atherosclerosis in patients with coronary risk factors. 20, 21 VWF is a multifunctional plasma protein that plays a very important role in hemostasis following vascular injury. As a consequence of vascular injury, the subendothelial matrix and collagen fibers are exposed to the blood flow. Circulating platelets adhere to the injured site and initiate the process of thrombosis. The present study has several limitations. Firstly, the sample size was relatively modest, so that further studies in larger scale are in need. Secondly, we did not demonstrate the mechanism involved in the increased plasma VWF. Thus, further prospective studies are needed in order to establish true mechanisms of chest pain in patients with increased plasma VWF, to render clues in searching a novel pharmaceutical therapy targeting endothelial dysfunction, and also to investigate the potential role of plasma VWF as an aide to risk stratification in patients with VA.
In conclusion, the increased level of VWF and decreased FMD are independently associated with VA.
Non-invasive evaluation of VWF and FMD may serve as useful markers for detecting endothelial dysfunction in the VA patients.
